GGrantIndex
← Leaderboards

Mark Myron Goodman

Emory University

$10,198,938
Attributed
$14,223,047
Total exposure
14
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200524
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$21,493,445 · 16

By mechanism

P50$7,837,107 · 3
R01$7,526,231 · 3
R21$3,074,396 · 5
R42$1,514,617 · 1
R33$672,741 · 1
P20$544,610 · 2

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImagePositron-Emission TomographyIn VivoLabelMagnetic Resonance ImagingMolecular ImagingBaseUptakeTracerContrast MediaMalignant NeoplasmsMetabolicImplantRattusImaging AgentTumorIn VitroPositronLigandsEarly DiagnosisAreaSpecificityEvaluationProperty

Grant awards (47)

Development of a PET CCR2 Imaging Agent to Profile PDAC Microenvironment$402,401
R21 · FY2024 · CA · contact PI
Design of Calcium-sensing Receptor Targeted Thera(g)nostic Agents$323,743
R41 · FY2024 · DK
Imaging bacterial infections with 2nd generation maltodextrins$664,310
R01 · FY2023 · EB
Imaging Bacterial Infections in Vivo: First in Man Studies$609,132
R42 · FY2023 · AI · contact PI
Imaging Bacterial Infections in Vivo: First in Man Studies$677,001
R42 · FY2022 · AI · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$667,650
R01 · FY2022 · EB
PET Imaging Agents for Protoporphyrin IX$215,101
R21 · FY2022 · CA · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$667,778
R01 · FY2021 · EB
Imaging Bacterial Infections in Vivo: First in Man Studies$228,484
R42 · FY2021 · AI · contact PI
PET Imaging Agents for Protoporphyrin IX$182,568
R21 · FY2021 · CA · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$710,274
R01 · FY2020 · EB
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$597,089
R01 · FY2018 · EB
PET Imaging Agents for 5-HT2C Receptors$234,000
R21 · FY2018 · MH · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$597,089
R01 · FY2017 · EB
PET Imaging Agents for 5-HT2C Receptors$234,000
R21 · FY2017 · MH · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$597,089
R01 · FY2016 · EB
PET Imaging Agents for 5-HT2C Receptors$234,000
R21 · FY2016 · MH · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$611,089
R01 · FY2015 · EB
Emory Molecular and Translational Imaging Center$1,070,400
P50 · FY2012 · CA
Leucine Type Amino Acid Transport In Gliomas$409,139
R01 · FY2012 · CA · contact PI
Tracer Development$123,039
P50 · FY2012 · CA · contact PI
Emory Molecular and Translational Imaging Center$1,200,000
P50 · FY2011 · CA
Leucine Type Amino Acid Transport In Gliomas$457,046
R01 · FY2011 · CA · contact PI
Tracer Development$120,390
P50 · FY2011 · CA · contact PI
Emory Molecular and Translational Imaging Center$1,500,000
P50 · FY2010 · CA
Tracer Development$136,325
P50 · FY2010 · CA · contact PI
Leucine Type Amino Acid Transport In Gliomas$28,022
R01 · FY2010 · CA · contact PI
Emory Molecular and Translational Imaging Center$1,500,000
P50 · FY2009 · CA
Leucine Type Amino Acid Transport In Gliomas$472,586
R01 · FY2009 · CA · contact PI
Tracer Development$135,830
P50 · FY2009 · CA · contact PI
Emory Molecular and Translational Imaging Center$1,500,000
P50 · FY2008 · CA
Leucine Type Amino Acid Transport In Gliomas$466,421
R01 · FY2008 · CA · contact PI
Tracer Development$87,275
P50 · FY2008 · CA · contact PI
Leucine Type Amino Acid Transport In Gliomas$580,649
R01 · FY2007 · CA · contact PI
Emory Molecular and Translational Imaging Center$499,998
P20 · FY2007 · CA
Core B: Tracer Development$44,612
P20 · FY2007 · CA · contact PI
Development and Applications of Novel SERT PET Ligands$335,726
R33 · FY2006 · MH · contact PI
Development and Applications of Novel SERT PET Ligands$337,015
R33 · FY2005 · MH
Development and Applications of Novel SERT PET Ligands$736,326
R21 · FY2004 · MH
Development of Novel Fluorinated Amino Acids$190,000
R21 · FY2004 · CA
Development and Applications of Novel SERT PET Ligands$228,000
R21 · FY2003 · MH
Development of Novel Fluorinated Amino Acids$190,000
R21 · FY2003 · CA
Development and Applications of Novel SERT PET Ligands$228,000
R21 · FY2002 · MH
Maternal depression: An adverse event for infants$0
P50 · FY2002 · MH
Maternal depression: An adverse event for infants$0
P50 · FY2001 · MH
Maternal depression: An adverse event for infants$231,924
P50 · FY2000 · MH
Maternal depression: An adverse event for infants$231,924
P50 · FY2000 · MH